66 results
Page 3 of 4
8-K
EX-99.1
td8a82q0uo7j1g4wlg
7 May 21
Business Highlights and 2021 Anticipated Milestones
7:00am
8-K
EX-99.1
hf6yi
18 Mar 21
Sutro Biopharma Reports Full Year 2020 Financial Results
7:00am
424B5
irdi3
9 Dec 20
Prospectus supplement for primary offering
4:02pm
424B5
o0punw4xtq
7 Dec 20
Prospectus supplement for primary offering
4:10pm
8-K
EX-99.1
3yi bb891
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-99.2
7hr3vbg
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-99.1
8p2 e9m67f6
9 Sep 20
Other Events
5:23pm
8-K
EX-99.1
f3kiwlfv1 y13u
15 Jun 20
Regulation FD Disclosure
7:21am
424B5
08ssx
12 May 20
Prospectus supplement for primary offering
5:02pm
424B5
3u9z4um3k ssgl3rx
11 May 20
Prospectus supplement for primary offering
4:12pm